LB80380

· LG Life Sciences

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for LB80380, covering 2009-05-08 to 2012-10-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B [Phase 2]